@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-BAFG-CSL2311093622 a mbo:MassSpectrum ;
    dcterms:creator "Kevin S. Jewell; Bj√∂rn Ehlig; Arne Wick" ;
    dcterms:date "2023-11-09"^^xsd:date ;
    dcterms:identifier "MSBNK-BAFG-CSL2311093622" ;
    dcterms:rights "Copyright 2023 Federal Institute of Hydrology, Koblenz, Germany under dl-de/by-2-0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "TripleTOF 5600 SCIEX" ;
            mbo:collision_energy "50" ;
            mbo:column_name "Zorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent" ;
            mbo:flow_gradient "0 min min 98% A, 1 min 98% A, 2 min 80% A, 16.5 min 2% A, 22 min 2% A, 22.1 min 98% A, 27 min 98% A" ;
            mbo:flow_rate "0.3 mL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:retention_time "9.345 min" ;
            mbo:solvent "A: Water 0.1% Formic acid, B: Acetonitrile 0.1% Formic acid" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Irbesartan" ;
            mbo:ch_compound_class "Pharmaceutical" ;
            mbo:ch_exact_mass 4.282325e+02 ;
            rdfs:seeAlso cas:138402-11-6 ;
            schema:inChI "InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)" ;
            schema:inChIKey inchikey:YOSHYTLCDANDAN-UHFFFAOYSA-N ;
            schema:molecularFormula "C25H28N6O" ;
            schema:name "Irbesartan" ;
            schema:smiles "CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5n[nH]nn5" ] ;
    mbo:has_peak [ mbo:intensity 9.2e+00 ;
            mbo:mz 8.00514e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 10 ],
        [ mbo:intensity 3.03e+01 ;
            mbo:mz 1.671543e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 33 ],
        [ mbo:intensity 9.8e+01 ;
            mbo:mz 1.780662e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 108 ],
        [ mbo:intensity 6.88e+01 ;
            mbo:mz 1.790727e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 76 ],
        [ mbo:intensity 3.869e+02 ;
            mbo:mz 1.800808e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 428 ],
        [ mbo:intensity 1.208e+02 ;
            mbo:mz 1.900652e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 134 ],
        [ mbo:intensity 3.79e+01 ;
            mbo:mz 1.910726e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 42 ],
        [ mbo:intensity 2.22e+02 ;
            mbo:mz 1.920764e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 245 ],
        [ mbo:intensity 9.63e+01 ;
            mbo:mz 1.951495e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 106 ],
        [ mbo:intensity 1.528e+02 ;
            mbo:mz 2.050764e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 169 ],
        [ mbo:intensity 3.52e+02 ;
            mbo:mz 2.060842e+02 ;
            mbo:peak_sequential_number 19 ;
            mbo:relative_intensity 389 ],
        [ mbo:intensity 8.63e+01 ;
            mbo:mz 8.40833e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 95 ],
        [ mbo:intensity 9.037e+02 ;
            mbo:mz 2.070915e+02 ;
            mbo:peak_sequential_number 20 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 9.8e+00 ;
            mbo:mz 3.862209e+02 ;
            mbo:peak_sequential_number 21 ;
            mbo:relative_intensity 11 ],
        [ mbo:intensity 9.3e+00 ;
            mbo:mz 1.400492e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 10 ],
        [ mbo:intensity 1.31e+01 ;
            mbo:mz 1.510542e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 14 ],
        [ mbo:intensity 2.32e+01 ;
            mbo:mz 1.520615e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 26 ],
        [ mbo:intensity 4.28e+01 ;
            mbo:mz 1.530691e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 47 ],
        [ mbo:intensity 2.07e+01 ;
            mbo:mz 1.650695e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 23 ],
        [ mbo:intensity 1.13e+01 ;
            mbo:mz 1.66073e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 12 ],
        [ mbo:intensity 9.8e+00 ;
            mbo:mz 1.670728e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 11 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz_value "429.2397"^^xsd:float ;
            mbo:precursor_type_value "[M+H]+" ] ;
    mbo:pk_num_peak 21 ;
    mbo:pk_splash "splash10-0a4i-0790000000-1747184ba28bde8f2adc" ;
    rdfs:comment "Acquisition method: 10.1002/rcm.8541" ;
    skos:definition "Irbesartan; LC-ESI-QTOF; MS2; 50 V" .

